Certara is a global leader in biosimulation, revolutionizing drug development through its comprehensive suite of advanced technologies and services. The company specializes in pharmacometrics, which involves the quantitative analysis of drug efficacy and safety, and integrates sophisticated modeling and simulation techniques to optimize drug development processes.
Certara’s offerings include a range of cutting-edge software platforms such as Phoenix®, Simcyp®, and D360®, designed to streamline drug development and regulatory submissions. Phoenix® facilitates complex pharmacokinetic and pharmacodynamic analyses, while Simcyp® provides advanced population modeling and simulation tools. D360® supports data management and visualization, enhancing decision-making throughout the drug development lifecycle.
In addition to their software solutions, Certara provides expert consulting services that cover various aspects of drug development, including regulatory strategy, clinical trial design, and risk assessment. Their expertise spans across pharmacokinetics, pharmacodynamics, and systems biology, enabling them to offer tailored solutions to address complex drug development challenges.
Certara’s mission is to accelerate the development of innovative therapies while improving patient safety and efficacy outcomes. By partnering with pharmaceutical and biotechnology companies, as well as regulatory agencies, Certara supports the creation of more effective and safer medications, driving advancements in the healthcare industry on a global scale. Their commitment to innovation and excellence helps bring new therapies to market faster and more efficiently, ultimately benefiting patients around the world.
